BioSpace News Archive

Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, today announced that on November 25, 2020, the Compensation Committee of Xeris’ Board of Directors granted non-qualified stock options for an aggregate of 18,000 shares, and restricted stock units for an aggregate of 70,200 s

- Canada is well positioned to obtain COVID-19 vaccines because of ongoing preparation over the last months. This work to provide every Canadian with access to a vaccine continues, and today, the Honourable Patty Hajdu, Minister of Health, and the Honourable Harjit S. Sajjan , Minister of National Defence, announced that Major-General Dany Fo

AIDS Healthcare Foundation, the world’s largest global AIDS organization, supports a proposal sent to the World Trade Organization by the EU and 13 other countries to remove impediments to trade in essential medical goods. LOS ANGELES--( BUSINESS WIRE )-- A block of 13 World Trade Organization (WTO) member countries and the EU, known as the Ottawa Group , issued a proposal on Monday urging other WTO members to refrain from imposing tariffs and expo

Theralase® Technologies Inc., a clinical-stage pharmaceutical company dedicated to the research and development of light activated PhotoDynamic Compounds and their associated drug formulations intended to safely and effectively destroy various cancers released its audited annual consolidated 3Q2020 financial statements.